Skip to Content

KIRA MENOPAUSE RELIEF FILM-COATED TABLETS

Active substance(s): CIMICIFUGA EXTRACT

View full screen / Print PDF » Download PDF ⇩
Transcript
a company of

Certification Mark

Patient Information Leaflet

Kira

®

Menopause relief

Mockup 02P0615 GB 540 3814/02

tablets
Black Cohosh root extract 6.5 mg

Please read this leaflet carefully before you start
taking these tablets. It contains some important
information about Kira® Menopause relief.
Keep this leaflet with the tablets. You may want to
read it again or show it to your doctor, pharmacist
or qualified healthcare practitioner.
What is in this leaflet
1. What this product is and what it is used for
2. Before you take this product
3. How to take this product
4. Possible side effects
5. How to store this product
6. Further information

1

1. What this product is and what it is used for
Kira® Menopause relief is a traditional herbal medicinal product containing Black Cohosh root.
Each film-coated tablet of this product contains
6.5 mg of extract (as dry extract) from Black Cohosh
rhizome and root (Cimicifuga racemosa (L.) Nutt.)
(4.5–8.5:1) (equivalent to 29.25–55.25 mg of Black
Cohosh). Extraction solvent: Ethanol 60 % v/v.

3. How to take this product:
Adults: For women experiencing menopausal
sym­p­toms, take 1 tablet daily. Tablets should be
taken at the same time of day if possible (morning
or evening). Swallow the tablet whole with some
water or other liquid. Do not chew the tablets.

Kira®  Menopause relief is a traditional herbal medicinal product for the relief of symptoms of the
menopause, such as hot flushes, night sweats,
and temporary changes in mood (such as nervous
irritability and restlessness). This usage is based
on traditional use only.

If you take too much of this product (overdose)
If you take more than the recommended dose,
speak to a doctor, pharmacist or qualified healthcare prac­tit­ioner and take this leaflet with you.

As there is evidence that Black Cohosh may have
hormone-like actions, it should only be used by
women of child-bearing potential if contraception
is used.
2. Before you take this product
Do not take this product if you:
– Have ever had or are suffering from liver or
kidney d
­ isease (e.g. hepatitis, jaundice or
cirrhosis)
– Have ever had or are suffering from an
oestrogen d
­ ependant tumour
– Are of child-bearing potential and do not use
contraception
– Are lactose-intolerant (react badly to lactose
or milk)
– Are pregnant or breast-feeding
– Are allergic to any of the ingredients (see
section 6)
– Are under the age of 18 years
Tell your doctor before taking this product if you:
– Have persistent history of menstrual disorders
– Are currently taking a medicine containing
oestrogen

2

Bezeichnung:

GI Kira Meno Tablets

Größe:

Inhalt:

30 überzogene Tabletten

Material:

Artikel-Nr.:

566168

Teile-Nr.:

Mockup

Druck-Kennz.:

02P0615

Laetus-Code:

540

EAN-Code:

Druckfarbe/
Winkelung bei
einer
Rasterweite
von 150 lpi

210 x 148 mm

Schwarz

45 °

If you forget to take this product
Continue to take your usual dose at the usual
time, it does not matter if you have missed a dose.
If you have any questions, or are unsure about
anything, please ask your doctor, pharmacist
or qualified healthcare practitioner.
4. Possible side effects
Like all medicines, this product can have side effects. These are listed below.
– Digestive upsets such as indigestion or
diarrhoea
– Facial swelling
– Allergic skin reactions such as nettle rash,
itching of the skin
If these persist for more than a few days, or become troublesome, stop taking this product. These
side effects are often only temporary. Stop taking
this product immediately if you experience any
allergic skin reaction.
Other side effects
Black Cohosh may rarely cause liver problems. If
you become unwell (yellowing eyes/skin, nausea,

3

Lackaussparung:

Datum: 12.06.2015 Versions-Nr.: 00-0

Sachbearbeiter G+G

Verwendete Schriften:

I)-

Prüfung und Freigabe Köln:

Björn Sund

VAG Rounded

II)-

q Frei

überprüft durch:

Helvetica

III)-

Andreas Ueberschär
q Neuer Abzug erforderlich
Prüfung und Freigabe Berlin:
q Frei

PZN-Code:
Land:

Do not exceed the stated dose.

Geprüft durch PPC:
q Ja

q Nein

EAN lesbar:
England

q Neuer Abzug erforderlich

q Ja

q Nein

Seite: 1 von 2

vomiting, dark urine, abdominal pain, unusual
tiredness) stop taking the product immediately
and seek medical advice.
Reporting of side effects
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not listed in this leaflet. You can also report
side effects directly via the Yellow Card Scheme,
Website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store this product
You must speak to a healthcare practitioner
– if your symptoms worsen
– if they do not improve after 12 weeks
– if you notice any re-appearance or changes in
menstrual bleeding.
Do not use your tablets after the expiry date.
Return any out-of-date tablets to your pharmacist
who will dispose of them for you. The expiry date
is printed on the box and the blister pack.

Mockup 02P0615 GB 540 3814/02

Store the tablets in a cool dry place.
Do not store the tablets in a place where the
temperature goes above 30 °C.
Keep your tablets out of the reach and sight of
children.
Keep your tablets in the blister pack until it is time
to take them.

6. Further information
Each film-coated tablet contains 6.5 mg of extract
(as dry extract) from Black Cohosh rhizome and
root (Cimicifuga racemosa (L.) Nutt. (4.5–8.5:1)
(equivalent to 29.25–55.25 mg of Black Cohosh).
Extraction solvent: Ethanol 60 % v/v.

If you would like further information about this
product, please contact:
Ceuta Healthcare Ltd.,
41 Richmond Hill,
BOURNEMOUTH BH2 6HS,
United Kingdom.

This product also contains the following ingredients:
Tablet core:
Cellulose powdered, lactose monohydrate, silica
colloidal anhydrous, magnesium stearate, maize
starch, cellulose microcrystalline, sodium starch
glycollate (type A)
Film-coating:
Hypromellose, macrogol 4000, titanium dioxide
(E171).

Telephone: 01202 780558
Fax: 01202 780559
Email.: info@ceutahealthcare.com

For a large print, Braille or audio version of this
leaflet, call Ceuta Healthcare Ltd.

If you think you have been told by your doctor that
you have an intolerance to some sugars, contact
your doctor before taking this product. Each
film-coated tablet contains 142 mg of lactose.
Each pack contains 30 film-coated tablets.
Registration holder for this product
Cassella-med GmbH & Co.KG
Gereonsmuehlengasse 1
50567 Cologne
Germany
Manufacturer of this product
Klosterfrau Berlin GmbH
Motzener Strasse 41
12277 Berlin
Germany

Cassella-med GmbH is a company of the

Traditional herbal registration number:
THR 29860/0002

4

6

5

Bezeichnung:

GI Kira Meno Tablets

Größe:

Inhalt:

30 überzogene Tabletten

Material:

Artikel-Nr.:

566168

Teile-Nr.:

Mockup

Druck-Kennz.:

02P0615

Laetus-Code:

540

EAN-Code:

Druckfarbe/
Winkelung bei
einer
Rasterweite
von 150 lpi

210 x 148 mm

Schwarz

45 °

Lackaussparung:

Datum: 12.06.2015 Versions-Nr.: 00-0

Sachbearbeiter G+G

Verwendete Schriften:

I)-

Prüfung und Freigabe Köln:

Björn Sund

VAG Rounded

II)-

q Frei

überprüft durch:

Helvetica

III)-

Andreas Ueberschär
q Neuer Abzug erforderlich
Prüfung und Freigabe Berlin:
q Frei

PZN-Code:
Land:

This leaflet was last revised May 2015.

Geprüft durch PPC:
q Ja

q Nein

EAN lesbar:
England

q Neuer Abzug erforderlich

q Ja

q Nein

Seite: 2 von 2

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide